People are currently driving the planet on a crash course with global stability. Something must be done.
The Scientist
Most Recent
Financial “conflicts of interest” should not be so quickly condemned. Industry relationships are unequivocally beneficial.
Researchers find a slew of new fungal species inhabiting the human gut, and suggest a link to an inflammatory bowel disease.
Researchers in Vienna are starting a Phase I trial on the first ever vaccine with a potential to treat the neurodegenerative disease.
How plants pass defenses to offspring through a complex molecular network
African justice systems must change to help curb HIV and tuberculosis transmission in prisons.
Why naked mole-rats and experimental gene therapies remind me of groundbreaking artists.
Is the push for science to save the still flailing economy a threat to scientific research?
Successful conservation depends on an economy that doesn’t incentivize destruction of species and habitats.
Amgen’s incomplete report on an early major trial of epoetin misled the medical community about the anemia drug’s risks and benefits—and helped make Amgen rich.
Follow The Scientist
Stay Connected with The Scientist
-
The Scientist Magazine
-
The Scientist Careers
-
Neuroscience Research Techniques
-
Genetic Research Techniques
-
Cell Culture Techniques
-
Microbiology and Immunology
-
Cancer Research and Technology
Current Issue
